Brain stem cell transplant patients may be able to take milder drugs
Parkinson’s disease patients who receive donor-derived brain stem cell therapy may be able to avoid potent immunosuppressant drugs without…
Articles by Lila Levinson, PhD
AI-designed Parkinson’s therapy prepares to move to clinical trials
An oral anti-inflammatory therapy for Parkinson’s disease developed using artificial intelligence (AI) may be nearing clinical trials. Insilico…
OM1 expands real-world data to help advance Parkinson’s research
OM1 has expanded a real-world dataset of people with neurological conditions, including Parkinson’s disease, adding health records and…
MJFF, Seal Rock collaboration eyes LRRK2 gene-targeting therapies
Seal Rock Therapeutics has joined a Michael J. Fox Foundation (MJFF) initiative to develop therapies targeted at the…
Foundation awards 44 grants to aid research into Parkinson’s disease
The Parkinson’s Foundation has announced that it will provide more than $4.3 million toward 44 research grants that seek…
Parkinson’s fall prevention program gets high marks from most users
Most people with Parkinson’s disease who’d experienced recurring falls found a personalized, home-based fall prevention program in Australia helpful…
Breathing low oxygen air could be new model for treating Parkinson’s
Continuous exposure to low-oxygen air halted neurodegeneration and eased or reversed motor symptoms in a mouse model of Parkinson’s…
Disease-modifying Parkinson’s therapy found safe in volunteers
ENERGI-F705PD, a potential disease-modifying therapy for Parkinson’s disease, was found to be safe and well tolerated in a Phase…
MJFF funds promising therapy tackling Parkinson’s progression
Lysoway Therapeutics has received a $2.93-million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The…
Living in poorer communities linked to worse Parkinson’s symptoms
People with Parkinson’s disease who live in disadvantaged communities tend to have more severe motor symptoms and greater motor…